US release

30 . 04 .2018
Press release
New Phase 4 OSCAR Trial Data Showed that Epiduo® Forte (adapalene and benzoyl peroxide) Gel, 0.3%/2.5% Decreased Acne Lesions Therefore Reducing the Risk of Scars in Moderate-to-Severe Acne Patients
  • U.S. release
READ MORE
05 . 03 .2018
Press release
Leading Acne Brand Launches First-Ever ​Retinoid Education Week
  • U.S. release
READ MORE
21 . 02 .2018
Press release
Differin® Expands Portfolio with the Addition of Two New Facial Skincare Products
  • U.S. release
READ MORE